nodes	percent_of_prediction	percent_of_DWPC	metapath
Fosaprepitant—Eye disorder—Etoposide—uterine cancer	0.00182	0.00182	CcSEcCtD
Fosaprepitant—Blood alkaline phosphatase increased—Epirubicin—uterine cancer	0.00182	0.00182	CcSEcCtD
Fosaprepitant—Flushing—Etoposide—uterine cancer	0.00181	0.00181	CcSEcCtD
Fosaprepitant—Cardiac disorder—Etoposide—uterine cancer	0.00181	0.00181	CcSEcCtD
Fosaprepitant—Hypersensitivity—Medroxyprogesterone Acetate—uterine cancer	0.00181	0.00181	CcSEcCtD
Fosaprepitant—Dizziness—Progesterone—uterine cancer	0.00179	0.00179	CcSEcCtD
Fosaprepitant—Angiopathy—Etoposide—uterine cancer	0.00177	0.00177	CcSEcCtD
Fosaprepitant—Immune system disorder—Etoposide—uterine cancer	0.00176	0.00176	CcSEcCtD
Fosaprepitant—Asthenia—Medroxyprogesterone Acetate—uterine cancer	0.00176	0.00176	CcSEcCtD
Fosaprepitant—Mediastinal disorder—Etoposide—uterine cancer	0.00176	0.00176	CcSEcCtD
Fosaprepitant—Pruritus—Medroxyprogesterone Acetate—uterine cancer	0.00174	0.00174	CcSEcCtD
Fosaprepitant—Vomiting—Progesterone—uterine cancer	0.00172	0.00172	CcSEcCtD
Fosaprepitant—Rash—Progesterone—uterine cancer	0.00171	0.00171	CcSEcCtD
Fosaprepitant—Dermatitis—Progesterone—uterine cancer	0.00171	0.00171	CcSEcCtD
Fosaprepitant—Headache—Progesterone—uterine cancer	0.0017	0.0017	CcSEcCtD
Fosaprepitant—Hot flush—Epirubicin—uterine cancer	0.00169	0.00169	CcSEcCtD
Fosaprepitant—Thrombophlebitis—Doxorubicin—uterine cancer	0.00169	0.00169	CcSEcCtD
Fosaprepitant—Blood alkaline phosphatase increased—Doxorubicin—uterine cancer	0.00168	0.00168	CcSEcCtD
Fosaprepitant—Diarrhoea—Medroxyprogesterone Acetate—uterine cancer	0.00168	0.00168	CcSEcCtD
Fosaprepitant—Menopausal symptoms—Epirubicin—uterine cancer	0.00168	0.00168	CcSEcCtD
Fosaprepitant—Decreased appetite—Dactinomycin—uterine cancer	0.00167	0.00167	CcSEcCtD
Fosaprepitant—Dysgeusia—Etoposide—uterine cancer	0.00166	0.00166	CcSEcCtD
Fosaprepitant—Fatigue—Dactinomycin—uterine cancer	0.00165	0.00165	CcSEcCtD
Fosaprepitant—Pain—Dactinomycin—uterine cancer	0.00164	0.00164	CcSEcCtD
Fosaprepitant—Muscle spasms—Etoposide—uterine cancer	0.00163	0.00163	CcSEcCtD
Fosaprepitant—Dizziness—Medroxyprogesterone Acetate—uterine cancer	0.00162	0.00162	CcSEcCtD
Fosaprepitant—Lethargy—Epirubicin—uterine cancer	0.00161	0.00161	CcSEcCtD
Fosaprepitant—Nausea—Progesterone—uterine cancer	0.00161	0.00161	CcSEcCtD
Fosaprepitant—Hyponatraemia—Epirubicin—uterine cancer	0.00159	0.00159	CcSEcCtD
Fosaprepitant—Osteoarthritis—Epirubicin—uterine cancer	0.00158	0.00158	CcSEcCtD
Fosaprepitant—Feeling abnormal—Dactinomycin—uterine cancer	0.00158	0.00158	CcSEcCtD
Fosaprepitant—Ill-defined disorder—Etoposide—uterine cancer	0.00158	0.00158	CcSEcCtD
Fosaprepitant—Anaemia—Etoposide—uterine cancer	0.00157	0.00157	CcSEcCtD
Fosaprepitant—Gastrointestinal pain—Dactinomycin—uterine cancer	0.00157	0.00157	CcSEcCtD
Fosaprepitant—Hot flush—Doxorubicin—uterine cancer	0.00156	0.00156	CcSEcCtD
Fosaprepitant—Vomiting—Medroxyprogesterone Acetate—uterine cancer	0.00156	0.00156	CcSEcCtD
Fosaprepitant—Menopausal symptoms—Doxorubicin—uterine cancer	0.00155	0.00155	CcSEcCtD
Fosaprepitant—Rash—Medroxyprogesterone Acetate—uterine cancer	0.00155	0.00155	CcSEcCtD
Fosaprepitant—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	0.00155	0.00155	CcSEcCtD
Fosaprepitant—Headache—Medroxyprogesterone Acetate—uterine cancer	0.00154	0.00154	CcSEcCtD
Fosaprepitant—Malaise—Etoposide—uterine cancer	0.00153	0.00153	CcSEcCtD
Fosaprepitant—Abdominal pain—Dactinomycin—uterine cancer	0.00151	0.00151	CcSEcCtD
Fosaprepitant—Body temperature increased—Dactinomycin—uterine cancer	0.00151	0.00151	CcSEcCtD
Fosaprepitant—Loss of consciousness—Etoposide—uterine cancer	0.00149	0.00149	CcSEcCtD
Fosaprepitant—Lethargy—Doxorubicin—uterine cancer	0.00149	0.00149	CcSEcCtD
Fosaprepitant—Cough—Etoposide—uterine cancer	0.00148	0.00148	CcSEcCtD
Fosaprepitant—Hyponatraemia—Doxorubicin—uterine cancer	0.00147	0.00147	CcSEcCtD
Fosaprepitant—Hypertension—Etoposide—uterine cancer	0.00147	0.00147	CcSEcCtD
Fosaprepitant—Osteoarthritis—Doxorubicin—uterine cancer	0.00146	0.00146	CcSEcCtD
Fosaprepitant—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.00146	0.00146	CcSEcCtD
Fosaprepitant—Chest pain—Etoposide—uterine cancer	0.00145	0.00145	CcSEcCtD
Fosaprepitant—Abdominal pain upper—Epirubicin—uterine cancer	0.00144	0.00144	CcSEcCtD
Fosaprepitant—Hypokalaemia—Epirubicin—uterine cancer	0.00144	0.00144	CcSEcCtD
Fosaprepitant—Unspecified disorder of skin and subcutaneous tissue—Etoposide—uterine cancer	0.00144	0.00144	CcSEcCtD
Fosaprepitant—Discomfort—Etoposide—uterine cancer	0.00143	0.00143	CcSEcCtD
Fosaprepitant—Toxic epidermal necrolysis—Epirubicin—uterine cancer	0.00142	0.00142	CcSEcCtD
Fosaprepitant—Aspartate aminotransferase increased—Epirubicin—uterine cancer	0.00142	0.00142	CcSEcCtD
Fosaprepitant—Hypersensitivity—Dactinomycin—uterine cancer	0.00141	0.00141	CcSEcCtD
Fosaprepitant—Muscular weakness—Epirubicin—uterine cancer	0.00139	0.00139	CcSEcCtD
Fosaprepitant—Alanine aminotransferase increased—Epirubicin—uterine cancer	0.00139	0.00139	CcSEcCtD
Fosaprepitant—Anaphylactic shock—Etoposide—uterine cancer	0.00139	0.00139	CcSEcCtD
Fosaprepitant—Infection—Etoposide—uterine cancer	0.00138	0.00138	CcSEcCtD
Fosaprepitant—Abdominal distension—Epirubicin—uterine cancer	0.00138	0.00138	CcSEcCtD
Fosaprepitant—Asthenia—Dactinomycin—uterine cancer	0.00137	0.00137	CcSEcCtD
Fosaprepitant—Skin disorder—Etoposide—uterine cancer	0.00135	0.00135	CcSEcCtD
Fosaprepitant—Hyperhidrosis—Etoposide—uterine cancer	0.00134	0.00134	CcSEcCtD
Fosaprepitant—Abdominal pain upper—Doxorubicin—uterine cancer	0.00134	0.00134	CcSEcCtD
Fosaprepitant—Hypokalaemia—Doxorubicin—uterine cancer	0.00133	0.00133	CcSEcCtD
Fosaprepitant—Toxic epidermal necrolysis—Doxorubicin—uterine cancer	0.00132	0.00132	CcSEcCtD
Fosaprepitant—Aspartate aminotransferase increased—Doxorubicin—uterine cancer	0.00132	0.00132	CcSEcCtD
Fosaprepitant—Diarrhoea—Dactinomycin—uterine cancer	0.00131	0.00131	CcSEcCtD
Fosaprepitant—Hypotension—Etoposide—uterine cancer	0.0013	0.0013	CcSEcCtD
Fosaprepitant—Muscular weakness—Doxorubicin—uterine cancer	0.00129	0.00129	CcSEcCtD
Fosaprepitant—Alanine aminotransferase increased—Doxorubicin—uterine cancer	0.00129	0.00129	CcSEcCtD
Fosaprepitant—Dysuria—Epirubicin—uterine cancer	0.00128	0.00128	CcSEcCtD
Fosaprepitant—Abdominal distension—Doxorubicin—uterine cancer	0.00127	0.00127	CcSEcCtD
Fosaprepitant—Pollakiuria—Epirubicin—uterine cancer	0.00126	0.00126	CcSEcCtD
Fosaprepitant—Photosensitivity reaction—Epirubicin—uterine cancer	0.00125	0.00125	CcSEcCtD
Fosaprepitant—Weight decreased—Epirubicin—uterine cancer	0.00124	0.00124	CcSEcCtD
Fosaprepitant—Dyspnoea—Etoposide—uterine cancer	0.00124	0.00124	CcSEcCtD
Fosaprepitant—Somnolence—Etoposide—uterine cancer	0.00123	0.00123	CcSEcCtD
Fosaprepitant—Infestation NOS—Epirubicin—uterine cancer	0.00122	0.00122	CcSEcCtD
Fosaprepitant—Infestation—Epirubicin—uterine cancer	0.00122	0.00122	CcSEcCtD
Fosaprepitant—Vomiting—Dactinomycin—uterine cancer	0.00122	0.00122	CcSEcCtD
Fosaprepitant—Stevens-Johnson syndrome—Epirubicin—uterine cancer	0.00121	0.00121	CcSEcCtD
Fosaprepitant—Rash—Dactinomycin—uterine cancer	0.00121	0.00121	CcSEcCtD
Fosaprepitant—Decreased appetite—Etoposide—uterine cancer	0.00121	0.00121	CcSEcCtD
Fosaprepitant—Gastrointestinal disorder—Etoposide—uterine cancer	0.0012	0.0012	CcSEcCtD
Fosaprepitant—Fatigue—Etoposide—uterine cancer	0.0012	0.0012	CcSEcCtD
Fosaprepitant—Stomatitis—Epirubicin—uterine cancer	0.00119	0.00119	CcSEcCtD
Fosaprepitant—Constipation—Etoposide—uterine cancer	0.00119	0.00119	CcSEcCtD
Fosaprepitant—Pain—Etoposide—uterine cancer	0.00119	0.00119	CcSEcCtD
Fosaprepitant—Conjunctivitis—Epirubicin—uterine cancer	0.00118	0.00118	CcSEcCtD
Fosaprepitant—Urinary tract infection—Epirubicin—uterine cancer	0.00118	0.00118	CcSEcCtD
Fosaprepitant—Dysuria—Doxorubicin—uterine cancer	0.00118	0.00118	CcSEcCtD
Fosaprepitant—Pollakiuria—Doxorubicin—uterine cancer	0.00117	0.00117	CcSEcCtD
Fosaprepitant—Haematuria—Epirubicin—uterine cancer	0.00116	0.00116	CcSEcCtD
Fosaprepitant—Photosensitivity reaction—Doxorubicin—uterine cancer	0.00115	0.00115	CcSEcCtD
Fosaprepitant—Weight decreased—Doxorubicin—uterine cancer	0.00114	0.00114	CcSEcCtD
Fosaprepitant—Feeling abnormal—Etoposide—uterine cancer	0.00114	0.00114	CcSEcCtD
Fosaprepitant—Nausea—Dactinomycin—uterine cancer	0.00114	0.00114	CcSEcCtD
Fosaprepitant—Gastrointestinal pain—Etoposide—uterine cancer	0.00113	0.00113	CcSEcCtD
Fosaprepitant—Infestation NOS—Doxorubicin—uterine cancer	0.00113	0.00113	CcSEcCtD
Fosaprepitant—Infestation—Doxorubicin—uterine cancer	0.00113	0.00113	CcSEcCtD
Fosaprepitant—Stevens-Johnson syndrome—Doxorubicin—uterine cancer	0.00112	0.00112	CcSEcCtD
Fosaprepitant—Bradycardia—Epirubicin—uterine cancer	0.00111	0.00111	CcSEcCtD
Fosaprepitant—Urticaria—Etoposide—uterine cancer	0.0011	0.0011	CcSEcCtD
Fosaprepitant—Stomatitis—Doxorubicin—uterine cancer	0.0011	0.0011	CcSEcCtD
Fosaprepitant—Abdominal pain—Etoposide—uterine cancer	0.0011	0.0011	CcSEcCtD
Fosaprepitant—Body temperature increased—Etoposide—uterine cancer	0.0011	0.0011	CcSEcCtD
Fosaprepitant—Urinary tract infection—Doxorubicin—uterine cancer	0.0011	0.0011	CcSEcCtD
Fosaprepitant—Conjunctivitis—Doxorubicin—uterine cancer	0.0011	0.0011	CcSEcCtD
Fosaprepitant—Hypoaesthesia—Epirubicin—uterine cancer	0.00109	0.00109	CcSEcCtD
Fosaprepitant—Urinary tract disorder—Epirubicin—uterine cancer	0.00108	0.00108	CcSEcCtD
Fosaprepitant—Haematuria—Doxorubicin—uterine cancer	0.00108	0.00108	CcSEcCtD
Fosaprepitant—Connective tissue disorder—Epirubicin—uterine cancer	0.00107	0.00107	CcSEcCtD
Fosaprepitant—Urethral disorder—Epirubicin—uterine cancer	0.00107	0.00107	CcSEcCtD
Fosaprepitant—Erythema multiforme—Epirubicin—uterine cancer	0.00103	0.00103	CcSEcCtD
Fosaprepitant—Bradycardia—Doxorubicin—uterine cancer	0.00103	0.00103	CcSEcCtD
Fosaprepitant—Eye disorder—Epirubicin—uterine cancer	0.00102	0.00102	CcSEcCtD
Fosaprepitant—Hypersensitivity—Etoposide—uterine cancer	0.00102	0.00102	CcSEcCtD
Fosaprepitant—Tinnitus—Epirubicin—uterine cancer	0.00102	0.00102	CcSEcCtD
Fosaprepitant—Cardiac disorder—Epirubicin—uterine cancer	0.00102	0.00102	CcSEcCtD
Fosaprepitant—Flushing—Epirubicin—uterine cancer	0.00102	0.00102	CcSEcCtD
Fosaprepitant—Hypoaesthesia—Doxorubicin—uterine cancer	0.00101	0.00101	CcSEcCtD
Fosaprepitant—Urinary tract disorder—Doxorubicin—uterine cancer	0.001	0.001	CcSEcCtD
Fosaprepitant—Asthenia—Etoposide—uterine cancer	0.000995	0.000995	CcSEcCtD
Fosaprepitant—Connective tissue disorder—Doxorubicin—uterine cancer	0.000995	0.000995	CcSEcCtD
Fosaprepitant—Angiopathy—Epirubicin—uterine cancer	0.000993	0.000993	CcSEcCtD
Fosaprepitant—Urethral disorder—Doxorubicin—uterine cancer	0.000992	0.000992	CcSEcCtD
Fosaprepitant—Immune system disorder—Epirubicin—uterine cancer	0.000988	0.000988	CcSEcCtD
Fosaprepitant—Mediastinal disorder—Epirubicin—uterine cancer	0.000986	0.000986	CcSEcCtD
Fosaprepitant—Pruritus—Etoposide—uterine cancer	0.000981	0.000981	CcSEcCtD
Fosaprepitant—Mental disorder—Epirubicin—uterine cancer	0.000958	0.000958	CcSEcCtD
Fosaprepitant—Erythema multiforme—Doxorubicin—uterine cancer	0.000957	0.000957	CcSEcCtD
Fosaprepitant—Malnutrition—Epirubicin—uterine cancer	0.000952	0.000952	CcSEcCtD
Fosaprepitant—Erythema—Epirubicin—uterine cancer	0.000952	0.000952	CcSEcCtD
Fosaprepitant—Diarrhoea—Etoposide—uterine cancer	0.000949	0.000949	CcSEcCtD
Fosaprepitant—Eye disorder—Doxorubicin—uterine cancer	0.000946	0.000946	CcSEcCtD
Fosaprepitant—Tinnitus—Doxorubicin—uterine cancer	0.000944	0.000944	CcSEcCtD
Fosaprepitant—Flushing—Doxorubicin—uterine cancer	0.000939	0.000939	CcSEcCtD
Fosaprepitant—Cardiac disorder—Doxorubicin—uterine cancer	0.000939	0.000939	CcSEcCtD
Fosaprepitant—Flatulence—Epirubicin—uterine cancer	0.000938	0.000938	CcSEcCtD
Fosaprepitant—Dysgeusia—Epirubicin—uterine cancer	0.000933	0.000933	CcSEcCtD
Fosaprepitant—Angiopathy—Doxorubicin—uterine cancer	0.000918	0.000918	CcSEcCtD
Fosaprepitant—Dizziness—Etoposide—uterine cancer	0.000917	0.000917	CcSEcCtD
Fosaprepitant—Muscle spasms—Epirubicin—uterine cancer	0.000916	0.000916	CcSEcCtD
Fosaprepitant—Immune system disorder—Doxorubicin—uterine cancer	0.000914	0.000914	CcSEcCtD
Fosaprepitant—Mediastinal disorder—Doxorubicin—uterine cancer	0.000912	0.000912	CcSEcCtD
Fosaprepitant—Mental disorder—Doxorubicin—uterine cancer	0.000887	0.000887	CcSEcCtD
Fosaprepitant—Ill-defined disorder—Epirubicin—uterine cancer	0.000884	0.000884	CcSEcCtD
Fosaprepitant—Vomiting—Etoposide—uterine cancer	0.000882	0.000882	CcSEcCtD
Fosaprepitant—Erythema—Doxorubicin—uterine cancer	0.000881	0.000881	CcSEcCtD
Fosaprepitant—Malnutrition—Doxorubicin—uterine cancer	0.000881	0.000881	CcSEcCtD
Fosaprepitant—Anaemia—Epirubicin—uterine cancer	0.00088	0.00088	CcSEcCtD
Fosaprepitant—Rash—Etoposide—uterine cancer	0.000874	0.000874	CcSEcCtD
Fosaprepitant—Dermatitis—Etoposide—uterine cancer	0.000873	0.000873	CcSEcCtD
Fosaprepitant—Headache—Etoposide—uterine cancer	0.000869	0.000869	CcSEcCtD
Fosaprepitant—Flatulence—Doxorubicin—uterine cancer	0.000868	0.000868	CcSEcCtD
Fosaprepitant—Dysgeusia—Doxorubicin—uterine cancer	0.000863	0.000863	CcSEcCtD
Fosaprepitant—Malaise—Epirubicin—uterine cancer	0.000859	0.000859	CcSEcCtD
Fosaprepitant—Syncope—Epirubicin—uterine cancer	0.000854	0.000854	CcSEcCtD
Fosaprepitant—Muscle spasms—Doxorubicin—uterine cancer	0.000847	0.000847	CcSEcCtD
Fosaprepitant—Palpitations—Epirubicin—uterine cancer	0.000842	0.000842	CcSEcCtD
Fosaprepitant—Loss of consciousness—Epirubicin—uterine cancer	0.000837	0.000837	CcSEcCtD
Fosaprepitant—Cough—Epirubicin—uterine cancer	0.000831	0.000831	CcSEcCtD
Fosaprepitant—Nausea—Etoposide—uterine cancer	0.000824	0.000824	CcSEcCtD
Fosaprepitant—Hypertension—Epirubicin—uterine cancer	0.000822	0.000822	CcSEcCtD
Fosaprepitant—Ill-defined disorder—Doxorubicin—uterine cancer	0.000818	0.000818	CcSEcCtD
Fosaprepitant—Anaemia—Doxorubicin—uterine cancer	0.000814	0.000814	CcSEcCtD
Fosaprepitant—Chest pain—Epirubicin—uterine cancer	0.000811	0.000811	CcSEcCtD
Fosaprepitant—Anxiety—Epirubicin—uterine cancer	0.000808	0.000808	CcSEcCtD
Fosaprepitant—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—uterine cancer	0.000805	0.000805	CcSEcCtD
Fosaprepitant—Discomfort—Epirubicin—uterine cancer	0.000801	0.000801	CcSEcCtD
Fosaprepitant—Malaise—Doxorubicin—uterine cancer	0.000795	0.000795	CcSEcCtD
Fosaprepitant—Dry mouth—Epirubicin—uterine cancer	0.000793	0.000793	CcSEcCtD
Fosaprepitant—Syncope—Doxorubicin—uterine cancer	0.00079	0.00079	CcSEcCtD
Fosaprepitant—Palpitations—Doxorubicin—uterine cancer	0.000779	0.000779	CcSEcCtD
Fosaprepitant—Anaphylactic shock—Epirubicin—uterine cancer	0.000777	0.000777	CcSEcCtD
Fosaprepitant—Oedema—Epirubicin—uterine cancer	0.000777	0.000777	CcSEcCtD
Fosaprepitant—Loss of consciousness—Doxorubicin—uterine cancer	0.000774	0.000774	CcSEcCtD
Fosaprepitant—Infection—Epirubicin—uterine cancer	0.000772	0.000772	CcSEcCtD
Fosaprepitant—Cough—Doxorubicin—uterine cancer	0.000769	0.000769	CcSEcCtD
Fosaprepitant—Shock—Epirubicin—uterine cancer	0.000765	0.000765	CcSEcCtD
Fosaprepitant—Nervous system disorder—Epirubicin—uterine cancer	0.000762	0.000762	CcSEcCtD
Fosaprepitant—Hypertension—Doxorubicin—uterine cancer	0.000761	0.000761	CcSEcCtD
Fosaprepitant—Skin disorder—Epirubicin—uterine cancer	0.000755	0.000755	CcSEcCtD
Fosaprepitant—Hyperhidrosis—Epirubicin—uterine cancer	0.000751	0.000751	CcSEcCtD
Fosaprepitant—Chest pain—Doxorubicin—uterine cancer	0.00075	0.00075	CcSEcCtD
Fosaprepitant—Anxiety—Doxorubicin—uterine cancer	0.000748	0.000748	CcSEcCtD
Fosaprepitant—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—uterine cancer	0.000745	0.000745	CcSEcCtD
Fosaprepitant—Discomfort—Doxorubicin—uterine cancer	0.000741	0.000741	CcSEcCtD
Fosaprepitant—Dry mouth—Doxorubicin—uterine cancer	0.000734	0.000734	CcSEcCtD
Fosaprepitant—Hypotension—Epirubicin—uterine cancer	0.000726	0.000726	CcSEcCtD
Fosaprepitant—Anaphylactic shock—Doxorubicin—uterine cancer	0.000719	0.000719	CcSEcCtD
Fosaprepitant—Oedema—Doxorubicin—uterine cancer	0.000719	0.000719	CcSEcCtD
Fosaprepitant—Infection—Doxorubicin—uterine cancer	0.000714	0.000714	CcSEcCtD
Fosaprepitant—Shock—Doxorubicin—uterine cancer	0.000707	0.000707	CcSEcCtD
Fosaprepitant—Nervous system disorder—Doxorubicin—uterine cancer	0.000705	0.000705	CcSEcCtD
Fosaprepitant—Insomnia—Epirubicin—uterine cancer	0.000703	0.000703	CcSEcCtD
Fosaprepitant—Skin disorder—Doxorubicin—uterine cancer	0.000698	0.000698	CcSEcCtD
Fosaprepitant—Hyperhidrosis—Doxorubicin—uterine cancer	0.000695	0.000695	CcSEcCtD
Fosaprepitant—Dyspnoea—Epirubicin—uterine cancer	0.000693	0.000693	CcSEcCtD
Fosaprepitant—Somnolence—Epirubicin—uterine cancer	0.000691	0.000691	CcSEcCtD
Fosaprepitant—Dyspepsia—Epirubicin—uterine cancer	0.000684	0.000684	CcSEcCtD
Fosaprepitant—Decreased appetite—Epirubicin—uterine cancer	0.000676	0.000676	CcSEcCtD
Fosaprepitant—Hypotension—Doxorubicin—uterine cancer	0.000672	0.000672	CcSEcCtD
Fosaprepitant—Gastrointestinal disorder—Epirubicin—uterine cancer	0.000671	0.000671	CcSEcCtD
Fosaprepitant—Fatigue—Epirubicin—uterine cancer	0.00067	0.00067	CcSEcCtD
Fosaprepitant—Pain—Epirubicin—uterine cancer	0.000665	0.000665	CcSEcCtD
Fosaprepitant—Constipation—Epirubicin—uterine cancer	0.000665	0.000665	CcSEcCtD
Fosaprepitant—Insomnia—Doxorubicin—uterine cancer	0.00065	0.00065	CcSEcCtD
Fosaprepitant—Dyspnoea—Doxorubicin—uterine cancer	0.000641	0.000641	CcSEcCtD
Fosaprepitant—Feeling abnormal—Epirubicin—uterine cancer	0.00064	0.00064	CcSEcCtD
Fosaprepitant—Somnolence—Doxorubicin—uterine cancer	0.000639	0.000639	CcSEcCtD
Fosaprepitant—Gastrointestinal pain—Epirubicin—uterine cancer	0.000636	0.000636	CcSEcCtD
Fosaprepitant—Dyspepsia—Doxorubicin—uterine cancer	0.000633	0.000633	CcSEcCtD
Fosaprepitant—Decreased appetite—Doxorubicin—uterine cancer	0.000625	0.000625	CcSEcCtD
Fosaprepitant—Gastrointestinal disorder—Doxorubicin—uterine cancer	0.000621	0.000621	CcSEcCtD
Fosaprepitant—Fatigue—Doxorubicin—uterine cancer	0.00062	0.00062	CcSEcCtD
Fosaprepitant—Urticaria—Epirubicin—uterine cancer	0.000617	0.000617	CcSEcCtD
Fosaprepitant—Pain—Doxorubicin—uterine cancer	0.000615	0.000615	CcSEcCtD
Fosaprepitant—Constipation—Doxorubicin—uterine cancer	0.000615	0.000615	CcSEcCtD
Fosaprepitant—Body temperature increased—Epirubicin—uterine cancer	0.000614	0.000614	CcSEcCtD
Fosaprepitant—Abdominal pain—Epirubicin—uterine cancer	0.000614	0.000614	CcSEcCtD
Fosaprepitant—Feeling abnormal—Doxorubicin—uterine cancer	0.000593	0.000593	CcSEcCtD
Fosaprepitant—Gastrointestinal pain—Doxorubicin—uterine cancer	0.000588	0.000588	CcSEcCtD
Fosaprepitant—Hypersensitivity—Epirubicin—uterine cancer	0.000573	0.000573	CcSEcCtD
Fosaprepitant—Urticaria—Doxorubicin—uterine cancer	0.000571	0.000571	CcSEcCtD
Fosaprepitant—Abdominal pain—Doxorubicin—uterine cancer	0.000568	0.000568	CcSEcCtD
Fosaprepitant—Body temperature increased—Doxorubicin—uterine cancer	0.000568	0.000568	CcSEcCtD
Fosaprepitant—Asthenia—Epirubicin—uterine cancer	0.000558	0.000558	CcSEcCtD
Fosaprepitant—Pruritus—Epirubicin—uterine cancer	0.00055	0.00055	CcSEcCtD
Fosaprepitant—Diarrhoea—Epirubicin—uterine cancer	0.000532	0.000532	CcSEcCtD
Fosaprepitant—Hypersensitivity—Doxorubicin—uterine cancer	0.00053	0.00053	CcSEcCtD
Fosaprepitant—Asthenia—Doxorubicin—uterine cancer	0.000516	0.000516	CcSEcCtD
Fosaprepitant—Dizziness—Epirubicin—uterine cancer	0.000514	0.000514	CcSEcCtD
Fosaprepitant—Pruritus—Doxorubicin—uterine cancer	0.000509	0.000509	CcSEcCtD
Fosaprepitant—Vomiting—Epirubicin—uterine cancer	0.000494	0.000494	CcSEcCtD
Fosaprepitant—Diarrhoea—Doxorubicin—uterine cancer	0.000492	0.000492	CcSEcCtD
Fosaprepitant—Rash—Epirubicin—uterine cancer	0.00049	0.00049	CcSEcCtD
Fosaprepitant—Dermatitis—Epirubicin—uterine cancer	0.00049	0.00049	CcSEcCtD
Fosaprepitant—Headache—Epirubicin—uterine cancer	0.000487	0.000487	CcSEcCtD
Fosaprepitant—Dizziness—Doxorubicin—uterine cancer	0.000476	0.000476	CcSEcCtD
Fosaprepitant—Nausea—Epirubicin—uterine cancer	0.000462	0.000462	CcSEcCtD
Fosaprepitant—Vomiting—Doxorubicin—uterine cancer	0.000457	0.000457	CcSEcCtD
Fosaprepitant—Rash—Doxorubicin—uterine cancer	0.000453	0.000453	CcSEcCtD
Fosaprepitant—Dermatitis—Doxorubicin—uterine cancer	0.000453	0.000453	CcSEcCtD
Fosaprepitant—Headache—Doxorubicin—uterine cancer	0.000451	0.000451	CcSEcCtD
Fosaprepitant—Nausea—Doxorubicin—uterine cancer	0.000427	0.000427	CcSEcCtD
